pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 7·1 min read
save

WHO briefs on hantavirus outbreak aboard cruise ship, Spain to allow docking in Canary Islands

May 7, 2026·read at STAT ↗Neutral

WHO held a press conference Thursday to update on a suspected hantavirus outbreak on the cruise ship MV Hondius.

The vessel is expected to dock in Tenerife, Canary Islands, after Spain agreed to the request of WHO director‑general Tedros Adhanom Ghebreyesus.

Health officials note this is the first suspected person‑to‑person transmission of hantavirus on a cruise vessel, and the investigation will take weeks because of the virus’s long incubation period.

Authorities from the United States and Argentina, both recently disengaged from WHO, are cooperating with the response, while scientists work to determine whether rodents on board contributed to the cases.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Key takeaways from WHO briefing on hantavirus cruise ship outbreak”

read at STAT ↗
1,442 words · retrieved May 7
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
JOURNEY2Ultragenyx Pharmaceutical Inc.2LEADINGSanofi
drugs
Obesity
topics
Rare Disease2Vaccine2Infectious DiseaseObesityPulmonology

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Estuary channels $93M series A; OMass obtains $310MFierce Biotech
  • Jun 15Covid vaccination cut risk of adverse heart events, large study findsSTAT
  • 3d agoSTAT+: Sanofi avoids fine as EU accepts offer to end antitrust probe over disparaging rival vaccineSTAT
  • Aug 12STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and moreSTAT